ADAPTIMMUNE THERAPEUTICS PLC Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss Current
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) had Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss Current of $0 as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Notes › Credit Loss, Additional Improvements
us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLossCurrent · last filed 2025-08-13
- 2025-06-30: Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss Current $0.00.
- 2025-03-31: Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss Current $18.51M.
- 2024-12-31: Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss Current $60.45M.
- 2024-09-30: Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss Current $69.29M.
| Period end | Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss Current |
|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 |
| 2025-03-31 | $18.51M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $60.45M 10-Q · filed 2025-08-13 |
| 2024-09-30 | $69.29M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $2.98M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $2.98M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $2.94M 10-K · filed 2025-03-24 |
| 2022-12-31 | $97.50M 10-K · filed 2024-03-06 |